Prestige Wealth Management Group’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $26.2K | Hold |
379
| – | – | 0.01% | 322 |
|
2025
Q1 | $26.8K | Hold |
379
| – | – | 0.01% | 314 |
|
2024
Q4 | $32.6K | Hold |
379
| – | – | 0.01% | 305 |
|
2024
Q3 | $45.1K | Hold |
379
| – | – | 0.01% | 256 |
|
2024
Q2 | $54.1K | Hold |
379
| – | – | 0.01% | 217 |
|
2024
Q1 | $49K | Hold |
379
| – | – | 0.01% | 254 |
|
2023
Q4 | $39.2K | Sell |
379
-15
| -4% | -$1.55K | 0.01% | 263 |
|
2023
Q3 | $35.8K | Hold |
394
| – | – | 0.01% | 268 |
|
2023
Q2 | $31.9K | Hold |
394
| – | – | 0.01% | 306 |
|
2023
Q1 | $31.6K | Sell |
394
-126
| -24% | -$10.1K | 0.01% | 276 |
|
2022
Q4 | $35.2K | Buy |
520
+52
| +11% | +$3.52K | 0.01% | 285 |
|
2022
Q3 | $23K | Sell |
468
-16
| -3% | -$786 | 0.01% | 296 |
|
2022
Q2 | $27K | Hold |
484
| – | – | 0.01% | 292 |
|
2022
Q1 | $27K | Hold |
484
| – | – | 0.01% | 301 |
|
2021
Q4 | $27K | Hold |
484
| – | – | 0.01% | 330 |
|
2021
Q3 | $23K | Hold |
484
| – | – | 0.01% | 352 |
|
2021
Q2 | $20K | Hold |
484
| – | – | 0.01% | 363 |
|
2021
Q1 | $16K | Sell |
484
-78
| -14% | -$2.58K | ﹤0.01% | 388 |
|
2020
Q4 | $20K | Sell |
562
-22
| -4% | -$783 | 0.01% | 355 |
|
2020
Q3 | $20K | Hold |
584
| – | – | 0.01% | 350 |
|
2020
Q2 | $19K | Sell |
584
-10
| -2% | -$325 | 0.01% | 343 |
|
2020
Q1 | $18K | Buy |
594
+584
| +5,840% | +$17.7K | 0.01% | 296 |
|
2019
Q4 | $0 | Hold |
10
| – | – | ﹤0.01% | 639 |
|
2019
Q3 | $0 | Buy |
+10
| New | – | ﹤0.01% | 625 |
|
2019
Q2 | – | Sell |
-766
| Closed | -$20K | – | 503 |
|
2019
Q1 | $20K | Sell |
766
-142
| -16% | -$3.71K | 0.01% | 280 |
|
2018
Q4 | $21K | Buy |
+908
| New | +$21K | 0.02% | 299 |
|